SEC Filing Analysis: Astera Labs, Inc.

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director proposes sale of ~$900k in stock under a pre-arranged 10b5-1 trading plan.
• Market Impact: Negligible; transaction represents a tiny fraction of market capitalization and daily volume.

Company Information

Field	Value
Company	Astera Labs, Inc.
CIK	0001736297
Industry	Semiconductors & Related Devices

Insider Information

Field	Value
Name	LAZAR JACK R
CIK	0001277624
Relationship	Director

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2026/03/05
Transaction Code	S
Security Type	Common
Shares Involved	7,500
Price Per Share	~$119.80 (Calculated)
Total Value	$898,471.25

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$898,471.25
% of Market Cap	0.004%
Shares Transacted	7,500
% of Shares Outstanding	0.004%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market cap of $20.23 billion, a ~$900k transaction is immaterial to the broader stock price.
• Transaction Significance: The transaction represents less than 0.01% of shares outstanding, indicating minimal selling pressure.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is small relative to the company's size and liquidity. It is conducted under a 10b5-1 plan, which removes signaling risk regarding current company performance.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• 10b5-1 Plan: The sale is pursuant to a plan adopted on 12/02/2025. This indicates the sale was scheduled months in advance and is not a reaction to recent news.
• Source of Shares: The shares being sold were acquired via Restricted Stock Units (RSUs) vesting on 11/15/2025 and 02/15/2026. This is a common pattern for directors monetizing compensation.